CDEK
← All organizations

Policlinico Casilino

Academic/HospitalWebsite ↗

Also known as: Policlinico Casilino | Policlinico Casilino ASL RMB

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Sep 1, 2013

Last known activity

Nov 1, 2020

Timeline

1990s

  1. Jul 1, 1995

    Policlinico Casilino— Founded

Drugs by trial phase (8 distinct, 5 trials)

Phase 4 (4 own, 0 via acquisition)

Phase 3 (4 own, 0 via acquisition)

Indications

Studied for

Recent trials (12)

  • NCT04659525Reponsible party - principal investigatorPhase 4Nov 1, 2020
  • NCT04659525Lead sponsorPhase 4Nov 1, 2020
  • NCT04397653Lead sponsorPhase 4May 4, 2020
  • NCT04397653Reponsible party - principal investigatorPhase 4May 4, 2020
  • NCT04163588Lead sponsorPhase 3Oct 1, 2019
  • NCT04163588Reponsible party - principal investigatorPhase 3Oct 1, 2019
  • NCT04163588Overall official - principal investigatorPhase 3Oct 1, 2019
  • NCT01868880Reponsible party - principal investigatorPhase 4Feb 1, 2016
  • NCT01868880Lead sponsorPhase 4Feb 1, 2016
  • NCT01657136Lead sponsorPhase 3Sep 1, 2013
  • NCT01657136Overall official - principal investigatorPhase 3Sep 1, 2013
  • NCT01657136Reponsible party - principal investigatorPhase 3Sep 1, 2013

Details

Founded
Rome, IT Jul 1, 1995
Last known activity
Nov 1, 2020